Spelling suggestions: "subject:"drimary human hepatocytes"" "subject:"drimary human hépatocytes""
1 |
Characterization of Phosphatidylcholine Metabolism in Mouse Hepatocytes after Hepatectomy and in Primary Human HepatocytesLing, Ji Unknown Date
No description available.
|
2 |
Applications of a humanized Serum-Free cell culture medium in drug ADMET: A Primary Human Hepatocyte and Caco-2 Model StudyPrimpas, Lazaros Ilias January 2024 (has links)
This study investigates the efficacy of a newly developed humanized serum-free media (SFM) that replaces Fetal Bovine Serum (FBS), in culturing of common in vitro models (Caco-2 and 3D Primary Human Hepatocytes (PHH)). The research’s focus aligns with the 3R principles (replacement, reduction, refinement) and may potentially lead to enhancing the human relevance of the in vitro models and ultimately contribute to more accurate and successful drug development in the future. This study is divided into two subprojects, Caco-2 and 3D PHH, respectively. For Caco-2, we evaluated cell morphology, proliferation and monolayer formation by assessing the permeability of marker compounds. For PHH, we investigated spheroid formation and viability using an ATP measurement assay, lipid concentration using an Adipored Assay and CYP activity of the 3D PHH. Finally, global proteomics analysis was performed for both Caco-2 cells and 3D PHH grown in SFM and in conventional medium (CM). Our findings show that Caco-2 cells could proliferate well enough in the SFMCaco-2 without any change in their cell morphology, whereas their monolayer tightness was found to be similar in SFMCaco-2 as compared to CMCaco-2. Furthermore, from the proteomics analysis there was no major difference detected between cells in SFMCaco-2 and in CMCaco-2, however several of the relevant drug transporters of this model were found in higher levels in Caco-2 cultured in SFMCaco-2. For 3D PHH, our findings indicate that spheroids could be perfectly formed in both SFM3D PHH and in CM3D PHH, having relatable viability and lipid concentration, especially after two week of culturing period. Finally, the proteomics analysis revealed no significant difference between the proteome of the spheroids when cultured in SFM3D PHH or in CM3D PHH. In conclusion, these results suggest that the SFM provides a viable and sometimes superior alternative to CM for both Caco-2 and 3D PHH, promoting the 3R principles and potentially offering a more human-relevant model for in vitro studies.
|
3 |
Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative StressRennert, Christiane, Heil, Theresa, Schicht, Gerda, Stilkerich, Anna, Seidemann, Lena, Kegel-Hübner, Victoria, Seehofer, Daniel, Damm, Georg 22 February 2024 (has links)
Overweight has become a major health care problem in Western societies and is
accompanied by an increasing incidence and prevalence of non-alcoholic fatty liver disease (NAFLD).
The progression from NAFLD to non-alcoholic steatohepatitis (NASH) marks a crucial tipping point
in the progression of severe and irreversible liver diseases. This study aims to gain further insight
into the molecular processes leading to the evolution from steatosis to steatohepatitis. Steatosis was
induced in cultures of primary human hepatocytes by continuous five-day exposure to free fatty
acids (FFAs). The kinetics of lipid accumulation, lipotoxicity, and oxidative stress were measured.
Additionally, ER stress was evaluated by analyzing the protein expression profiles of its key players:
PERK, IRE1a, and ATF6a. Our data revealed that hepatocytes are capable of storing enormous
amounts of lipids without showing signs of lipotoxicity. Prolonged lipid accumulation did not create
an imbalance in hepatocyte redox homeostasis or a reduction in antioxidative capacity. However, we
observed an FFA-dependent increase in ER stress, revealing thresholds for triggering the activation of
pathways associated with lipid stress, inhibition of protein translation, and apoptosis. Our study
clearly showed that even severe lipid accumulation can be attenuated by cellular defenses, but
regenerative capacities may be reduced.
|
4 |
Primary-like Human Hepatocytes Genetically Engineered to Obtain Proliferation Competence as a Capable Application for Energy Metabolism Experiments in In Vitro Oncologic Liver ModelsScheffschick, Andrea, Babel, Jonas, Sperling, Sebastian, Nerusch, Julia, Herzog, Natalie, Seehofer, Daniel, Damm, Georg 06 December 2023 (has links)
Non-alcoholic fatty liver disease (NAFLD), characterized by lipid accumulation in the liver,
is the most common cause of liver diseases in Western countries. NAFLD is a major risk factor for
developing hepatocellular carcinoma (HCC); however, in vitro evaluation of hepatic cancerogenesis
fails due to a lack of liver models displaying a proliferation of hepatocytes. Originally designed
to overcome primary human hepatocyte (PHH) shortages, upcyte hepatocytes were engineered
to obtain continuous proliferation and, therefore, could be a suitable tool for HCC research. We
generated upcyte hepatocytes, termed HepaFH3 cells, and compared their metabolic characteristics to
HepG2 hepatoma cells and PHHs isolated from resected livers. For displaying NAFLD-related HCCs,
we induced steatosis in all liver models. Lipid accumulation, lipotoxicity and energy metabolism
were characterized using biochemical assays and Western blot analysis. We showed that proliferating
HepaFH3 cells resemble HepG2, both showing a higher glucose uptake rate, lactate levels and
metabolic rate compared to PHHs. Confluent HepaFH3 cells displayed some similarities to PHHs,
including higher levels of the transaminases AST and ALT compared to proliferating HepaFH3 cells.
We recommend proliferating HepaFH3 cells as a pre-malignant cellular model for HCC research,
while confluent HepaFH3 cells could serve as PHH surrogates for energy metabolism studies.
|
5 |
Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic SteatosisSeidemann, Lena, Krüger, Anne, Kegel-Hübner, Victoria, Seehofer, Daniel, Damm, Georg 05 May 2023 (has links)
Nonalcoholic fatty liver disease (NAFLD) is among the leading causes of end-stage liver disease. The impaired hepatic lipid metabolism in NAFLD is exhibited by dysregulated PPARα and SREBP-1c signaling pathways, which are central transcription factors associated with lipid degradation and de novo lipogenesis. Despite the growing prevalence of this disease, current pharmacological treatment options are unsatisfactory. Genistein, a soy isoflavone, has beneficial effects on lipid metabolism and may be a candidate for NAFLD treatment. In an in vitro model of hepatic steatosis, primary human hepatocytes (PHHs) were incubated with free fatty acids (FFAs) and different doses of genistein. Lipid accumulation and the cytotoxic effects of FFAs and genistein treatment were evaluated by colorimetric and enzymatic assays. Changes in lipid homeostasis were examined by RT-qPCR and Western blot analyses. PPARα protein expression was induced in steatotic PHHs, accompanied by an increase in CPT1L and ACSL1 mRNA. Genistein treatment increased PPARα protein expression only in control PHHs, while CPTL1 and ACSL1 were unchanged and PPARα mRNA was reduced. In steatotic PHHs, genistein reversed the increase in activated SREBP-1c protein. The model realistically reflected the molecular changes in hepatic steatosis. Genistein suppressed the activation of SREBP-1c in steatotic hepatocytes, but the genistein-mediated effects on PPARα were abolished by high hepatic lipid levels.
|
6 |
Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative StressRennert, Christiane, Heil, Theresa, Schicht, Gerda, Stilkerich, Anna, Seidemann, Lena, Kegel-Hübner, Victoria, Seehofer, Daniel, Damm, Georg 26 February 2024 (has links)
Overweight has become a major health care problem in Western societies and is
accompanied by an increasing incidence and prevalence of non-alcoholic fatty liver disease (NAFLD).
The progression from NAFLD to non-alcoholic steatohepatitis (NASH) marks a crucial tipping point
in the progression of severe and irreversible liver diseases. This study aims to gain further insight
into the molecular processes leading to the evolution from steatosis to steatohepatitis. Steatosis was
induced in cultures of primary human hepatocytes by continuous five-day exposure to free fatty
acids (FFAs). The kinetics of lipid accumulation, lipotoxicity, and oxidative stress were measured.
Additionally, ER stress was evaluated by analyzing the protein expression profiles of its key players:
PERK, IRE1a, and ATF6a. Our data revealed that hepatocytes are capable of storing enormous
amounts of lipids without showing signs of lipotoxicity. Prolonged lipid accumulation did not create
an imbalance in hepatocyte redox homeostasis or a reduction in antioxidative capacity. However, we
observed an FFA-dependent increase in ER stress, revealing thresholds for triggering the activation of
pathways associated with lipid stress, inhibition of protein translation, and apoptosis. Our study
clearly showed that even severe lipid accumulation can be attenuated by cellular defenses, but
regenerative capacities may be reduced.
|
7 |
Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic CapacityRuoß, Marc, Damm, Georg, Vosough, Massoud, Ehret, Lisa, Grom-Baumgarten, Carl, Petkov, Martin, Naddalin, Silvio, Ladurner, Ruth, Seehofer, Daniel, Nussler, Andreas, Sajadian, Sahar 11 January 2024 (has links)
Although human liver tumor cells have reduced metabolic functions as compared to
primary human hepatocytes (PHH) they are widely used for pre-screening tests of drug metabolism
and toxicity. The aim of the present study was to modify liver cancer cell lines in order to improve
their drug-metabolizing activities towards PHH. It is well-known that epigenetics is strongly modified
in tumor cells and that epigenetic regulators influence the expression and function of Cytochrome
P450 (CYP) enzymes through altering crucial transcription factors responsible for drug-metabolizing
enzymes. Therefore, we screened the epigenetic status of four different liver cancer cell lines (Huh7,
HLE, HepG2 and AKN-1) which were reported to have metabolizing drug activities. Our results
showed that HepG2 cells demonstrated the highest similarity compared to PHH. Thus, we modified
the epigenetic status of HepG2 cells towards ‘normal’ liver cells by 5-Azacytidine (5-AZA) and Vitamin
C exposure. Then, mRNA expression of Epithelial-mesenchymal transition (EMT) marker SNAIL
and CYP enzymes were measured by PCR and determinate specific drug metabolites, associated
with CYP enzymes by LC/MS. Our results demonstrated an epigenetic shift in HepG2 cells towards
PHH after exposure to 5-AZA and Vitamin C which resulted in a higher expression and activity of
specific drug metabolizing CYP enzymes. Finally, we observed that 5-AZA and Vitamin C led to
an increased expression of Hepatocyte nuclear factor 4α (HNF4α) and E-Cadherin and a significant
down regulation of Snail1 (SNAIL), the key transcriptional repressor of E-Cadherin. Our study
shows, that certain phase I genes and their enzyme activities are increased by epigenetic modification
in HepG2 cells with a concomitant reduction of EMT marker gene SNAIL. The enhancing of liver
specific functions in hepatoma cells using epigenetic modifiers opens new opportunities for the usage
of cell lines as a potential liver in vitro model for drug testing and development.
|
8 |
Activation métabolique et génotoxicité des Amines Hétérocycliques Aromatiques (AHA) chez l’Homme / Metabolic activation and genotoxicity of Heterocyclic Amines Aromatics (AHA) in humansBellamri, Medjda 08 April 2016 (has links)
Les amines hétérocycliques aromatiques (AHA) sont des contaminants de l'environnement et de l'alimentation, majoritairement formés lors de la cuisson de viande et poisson ainsi que dans la fumée de cigarette et les gaz d'échappements. Les AHA sont mutagènes chez la bactérie, cancérogènes multi-sites chez le rongeur et sont classées comme cancérogènes possibles ou probables chez l'Homme par l'IARC. Il est aujourd'hui indispensable de caractériser des biomarqueurs d'exposition dérivés des AHA (adduits à l'ADN et métabolites) pour améliorer l'estimation du risque chez l'Homme. Des résultats de l'équipe ont démontré que le 2-amino-9H-pyrido[2,3-b]indole (AαC) forme des niveaux d'adduits à l'ADN élevés dans les hépatocytes humains. Ces niveaux sont plus élevés que ceux formés par les autres AHA. L'objectif de cette thèse est de mieux comprendre le potentiel génotoxique d'AαC chez l'Homme. Nos travaux ont démontré que les adduits à l'ADN dérivés d'AαC sont persistants dans les hépatocytes humains et formés à des doses aussi faibles que 1nM. De plus, le CYP1A2 a été confirmé comme enzyme majoritaire dans la bioactivation d'AαC dans le foie humain. Nous avons également caractérisé les métabolites majeurs dérivés d'AαC dans les hépatocytes humains. Cette étude a permis d'établir pour la première fois une corrélation entre l'activité catalytique du CYP1A2, la formation d'AαC-HN2-O-Gl et la formation des adduits à l'ADN dérivés d'AαC. Le métabolite AαC-HN2-O-Gl étant réactif vis-à-vis de l'ADN in vitro, nos travaux confortent l'hypothèse que la voie des UDP-Glucuronosyltransférases (UGTs) est une nouvelle voie de bioactivation d'AαC dans le foie humain. De plus, nous avons montré que les adduits à l'ADN dérivés des AHA sont formés dans les lymphocytes T humains activés et en particulier les adduits en position C8 de la guanine dérivés d'AαC. Au total, ces travaux ont permis l'identification de métabolites stables et des adduits à l'ADN, potentiels biomarqueurs d'exposition à AαC, qui sont indispensables pour une meilleure estimation du risque génotoxique d'AαC chez l'Homme. / Heterocyclic aromatic amines (HAA) are environmental and food contaminants, mainly formed during meat and fish cooking, but also in cigarette smoke and exhaust gaz. HAA are mutagenic in bacteria, carcinogenic in rodents and are classified as possible or probable human carcinogens by IARC. Today it is essential to characterize exposure biomarkers i.e. DNA adducts and metabolites, to assess the human risk associated with HAA. The research team has previously demonstrated that 2-amino-9H-pyrido[2,3-b]indole (AαC) form high levels of DNA adducts in human hepatocytes. These levels are greater that those derived from other HAAs. Thus, the aim of this thesis was to better understand the genotoxic potential of AαC in human. We demonstrated that in human hepatocytes, DNA adducts derived from AαC are persistent and formed at doses as low as 1nM. Moreover, we confirmed that CYP1A2 is the major enzyme implicated in the bioactivation of AαC in human liver. We have also characterized the major metabolites derived from AαC formed in human hepatocytes. This study allows, for the first time, the establishment of a correlation between the catalytic activity of CYP1A2, AαC-HN2-O-Gl formation and AαC derived DNA adducts formation. AαC-HN2-O-Gl being reactive toward DNA in vitro, our work reinforces the hypothesis that the UDP-glucuronosyltransferase (UGTs) pathway is a new bioactivation pathway for AαC in human liver. Moreover, we demonstrated the formation of HAA derived DNA adducts, especially those derived from AαC at position C8 of guanine, in activated human T lymphocytes. Taken together, our data lead to the identification of stable metabolites as well as DNA adducts which are potentials AαC exposure biomarkers in human. These biomarkers are essential for a better assessment of the genotoxic risk of AαC in human.
|
9 |
Phosphatidylinositol 4 -Kinases de type III hépatiques : implication au cours de l'infection par le virus de l'hépatite C et lien avec le carcinome hépatocellulaire / Type III Phosphatidylinositol 4-kinases in the liver : involvement during Hepatitis C Virus infection and link with hepatocellular carcinomaIlboudo, Adeodat 08 July 2013 (has links)
Le virus de l’hépatite C (VHC) est l’un des principaux facteurs étiologiques du carcinome hépatocellulaire. Le traitement des hépatites virales C a été récemment amélioré grâce à une trithérapie (interféron, ribavirine et anti-protéase virale). Néanmoins l’importance des effets secondaires et l’émergence de mutants résistants nécessitent de découvrir de nouveaux antiviraux. Dans ce contexte, notre équipe a récemment découvert que les phosphatidylinositol 4-kinases de type III (PI4KIIIα et PI4KIIIβ) étaient indispensables à la propagation du virus dans une lignée hépatique humaine, et ce, à 2 étapes de son cycle biologique : l’entrée et la réplication. L’objectif du présent travail était de poursuivre la validation de ces nouvelles cibles thérapeutiques potentielles, en approfondissant nos connaissances sur la dépendance du virus à l’égard de ces kinases au cours de son entrée. Pour cela, nous avons utilisé le modèle des hépatocytes humains primaires, système in vitro plus proche du contexte physiologique que les modèles utilisés jusqu’à présent et qui étaient basés sur l’exploitation de lignées. Deux axes ont été développés : Vérification de l’importance de l’activité kinase des PI4KIIIs au cours de l’entrée du VHC dans les hépatocytes humains primaires, à travers une approche chimique ; Validation de l’implication de ces kinases et de leur activité enzymatique au cours de l’entrée virale grâce à une approche génétique basée sur l’ARN interférence et la restauration de phénotype. En parallèle, nous avons étudié l’expression de PI4KIIIα au cours de pathologies hépatiques. Nos résultats suggèrent une implication de PI4KIIIα au cours de l’entrée du VHC dans les hépatocytes humains primaires, mais restent à confirmer quant à l’implication de PI4KIIIβ. Par ailleurs, l’analyse de l’expression de PI4KIIIα dans le carcinome hépatocellulaire (CHC) conduit à proposer cette kinase comme un nouveau marqueur moléculaire, qui pourrait améliorer les modèles de pronostic déjà établis et pourrait conduire au développement de nouvelles approches thérapeutiques pour les patients atteints d’un CHC, quelque soit l’étiologie. / Hepatitis C virus (HCV) is one of the leading causes of hepatocellular carcinoma. Therapeutic treatment against the virus has been recently improved by a tritherapy including pegylated interferon, ribavirin and antiviral protease. Nevertheless, the importance of side effects and the emergence of resistant mutants require the development of new antivirals. In this context, our team has recently discovered that Type III phosphatidylinositol 4-kinases (PI4KIIIα and PI4KIIIβ) are essential for the propagation of the virus in a human hepatic cell line at the entry and replication steps. To further characterize these potential therapeutic targets, we investigate the implication of these kinases during the HCV entry, using primary human hepatocytes, a model closer to the in vivo conditions. Two lines of research were developed: Verification of the importance of the kinase activity of PI4KIIIs during HCV entry in primary human hepatocytes, through a chemical approach; Validation of the involvement of these kinases and their enzymatic activity during viral entry through a genetic approach based on RNA interference and phenotype rescue. In parallel, we studied the expression of PI4KIIIα in liver diseases. Our results suggest the involvement of PI4KIIIα in HCV entry; the involvement of PI4KIIIIβ needs to be confirmed. The analysis of PI4KIIIα expression in hepatocellular carcinoma led us to propose this kinase as a new molecular marker, which could improve the already established prognosis models and could lead to the development of new therapeutic approaches.
|
10 |
Der Leptinrezeptor im Modell primärer humaner HepatozytenLorz, Axel 11 August 2014 (has links) (PDF)
Diese Arbeit beinhaltet Untersuchungen zu den unterschiedlichen Isoformen des Leptinrezeptors und dessen Regulation in primären humanen Hepatozyten. Leptin und der Leptinrezeptor nehmen in der Physiologie des menschlichen Energiehaushaltes eine wesentliche Funktion ein und sind an der Pathogenese der Adipositas mit Folgeerkrankungen wie der Entwicklung einer Fettleber beteiligt. Es wird erstmalig geprüft inwieweit das Modellsystem primärer humaner Hepatozyten für Analysen der Leptinrezeptor-Expression und der Abspaltung von löslichem Leptinrezeptor geeignet ist. Weiterhin werden untersucht, welchen Einfluss endokrine Regulatoren wie Dexamethason, Leptin und Glucagon auf die isoformspezifischen Rezeptormengen in primären Hepatozyten haben und wie der Rezeptor unter Apoptose reguliert ist, welche durch die lipotoxischen Effekte der freien Fettsäure Palmitat und den Apoptoseinduktor Staurosporin induziert wird. Hierdurch können Rückschlüsse auf eine möglicherweise veränderte Wirksamkeit des Leptins in der Leber gezogen werden.
|
Page generated in 0.4386 seconds